https://investor.ironwoodpharma.com/press-releases/press-release-details/2010/Ironwood-and-Forest-Announce-Positive-Linaclotide-Results-from-Phase-3-Trial-in-Patients-with-Irritable-Bowel-Syndrome-with-Constipation/default.aspx
Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients.
- September 13, 2010